Nureca Ltd.

288.95 -3.75 ▼-1.3%

25 April 2024, 04:03:39 PM
Volume: 18,542

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Industry Icon Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.nureca.com
Market Cap 289.91 Cr.
Enterprise Value(EV) 232.69 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.82 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 352.68 Trailing Twelve Months Ending 2023-12
Industry PE 57.49 Trailing Twelve Months Ending 2023-12
Book Value / Share 197.20 Trailing Twelve Months Ending 2023-12
Price to Book Value 1.47 Calculated using Price: 289.90
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.00 Cr. 10,000,175 Shares
FaceValue 10
About Nureca Ltd.
Nureca is a B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs. It enables its customers with tools to help them monitor chronic ailments and other diseases, to improve their lifestyle. It is a digital first company wherein it sells its products through online channel partners such as e-commerce players, distributors and retailer. Further, it also sells its products through its own website drtrust.in.

Nureca Ltd. Delivery

Delivered Qty
Traded Qty

Nureca Ltd. Performance

1 Day
-1.28%
1 Week
+3.66%
1 Month
-1.68%
3 Month
-21.91%
6 Month
-15.38%
1 Year
-12.69%
2 Year
-79.06%
5 Year
10 Year

Nureca Ltd. Fundamental Ratios

6 years 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 426.3 162.03 61.23 52.39 24.55 -4.14
Return on Capital Employed (%) 255.06 179.97 56.7 67.61 33.57 -5.17
Return on Assets (%) 44.35 40.78 22.3 41.38 20.33 -3.62

Nureca Ltd. Balance Sheet

Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 2 8 15 163 203 195 197
Non Curr. Liab. 0 0 9 3 4 0 0
Curr. Liab. 5 15 10 24 45 9 9
Minority Int.
Equity & Liab. 7 24 34 190 252 204 207
Non Curr. Assets 0 1 1 4 13 17 12
Curr. Assets 7 23 33 186 239 187 195
Misc. Exp. not W/O
Total Assets 7 24 34 190 252 204 207

Nureca Ltd. Profit and Loss

Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 20 62 99 213 256 111 96
Other Income 0 0 0 3 8 7 14
Total Income 20 62 99 216 263 118 110
Total Expenditure -16 -53 -90 -152 -200 -126 -105
PBIDT 4 9 10 64 63 -8 5
Interest 0 0 -1 -2 -1 0 0
Depreciation 0 0 0 0 -1 -2 -2
Taxation -1 -3 -2 -16 -16 2 -1
Exceptional Items
PAT 3 6 6 46 45 -8 1
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 3 6 6 46 45 -8 1
Adjusted EPS 445 889 914 46 45 -8 1

Nureca Ltd. Cash Flow

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -8 35 1 10
Cash Fr. Inv. 0 0 0 -110 -3 -16
Cash Fr. Finan. 0 0 8 92 -7 -2
Net Change 0 0 0 17 -9 -8
Cash & Cash Eqvt 0 0 0 17 8 1

Nureca Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 70.00 70.00 70.00 62.98 62.98 62.98 63.24 63.24 63.24
Public 30.00 30.00 30.00 37.02 37.02 37.02 36.76 36.76 36.76
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Nureca Ltd. Announcements

Tue, 02 Apr 2024
Press Release
Nureca Limited has informed the Exchange regarding a press release dated April 02, 2024, titled "Nureca Limited's Dr Trust Recognized as a 'Well Known Trademark' by the Indian Trademark Registry".
Wed, 27 Mar 2024
Trading Window
Nureca Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Wed, 27 Mar 2024
Trading Window-XBRL
NURECA LIMITED has informed the Exchange about Closure of Trading Window

Nureca Ltd. Technical Scans

Wed, 24 Apr 2024
High Decrease in 3 Months High Decrease in 3 Months
High Decrease in 2 Years High Decrease in 2 Years
5 SMA Crossing 20 SMA From Below 5 SMA Crossing 20 SMA From Below
MFI Trending Down MFI Trending Down
Close Above Last Week High Close Above Last Week High

Nureca Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,830.88 1,520.15 +2.3%
Cipla Ltd. 113,471.29 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. 103,713.42 6,218.75 +4.5%
Divi's Laboratories Ltd. 101,959.84 3,843.80 +0.8%
Zydus Lifesciences Ltd. 95,944.41 951.25 +1.9%
Mankind Pharma Ltd. 95,926.91 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. 91,425.47 6,384.10 +1.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.96 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 30.60 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.84 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-12 73.73 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.26 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-12 55.54 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.83 6,384.10 +1.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 4.38 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.86 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.82 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.09 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-12 10.80 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.54 6,384.10 +1.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,384.10 +1.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,384.10 +1.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,384.10 +1.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,384.10 +1.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,384.10 +1.6%

Nureca Ltd. FAQ's

What is Nureca Ltd. share price?

Can I buy Nureca Ltd. shares now?

What is the Market Cap of Nureca Ltd.?

What are the key metrics to analyse Nureca Ltd.?

What is the 52 Week High and Low of Nureca Ltd.?

What is the trend of Nureca Ltd. share price?